Transviragen Inc.

Chapel Hill, NC

UEI
LNRAJQKEWYL4
CAGE
5GQB7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Business
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Taylor, Isaac M Hall, 109 Mason Farm Rd, Chapel Hill, NC 27514, USA
Founded
2009
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Custom tranviragen services HHSN272201501069P National Institute of Allergy and Infectious Diseases (NIH) $39,050
Genetically manipulated mice HHSF223201300322A Food and Drug Administration $149,921
Transgenic mouse generation HHSF223201210284A Food and Drug Administration $8,056

SBA capabilities narrative

TransViragen provides molecular biology, cell biology and animal model research services, including the generation and analysis of genetically modified rodents and cell lines.

Quick answers

Is Transviragen Inc. registered in SAM.gov?

Yes. Transviragen Inc.'s SAM.gov registration is active through March 24, 2027.

What is Transviragen Inc.'s most recent federal award?

Transviragen Inc.'s most recent federal contract award is Custom tranviragen services (HHSN272201501069P), from National Institute of Allergy and Infectious Diseases (NIH), on August 14, 2015.

On GovTribe

See Transviragen Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors